No Data
No Data
Express News | Ensysce Biosciences Secures Commercial Supplier For PF614-MPAR Overdose Protection Drug, Fully Establishing Supply Chain With GMP Nafamostat From Aurore Life Sciences
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Ensysce Biosciences Trading Halted, News Pending
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Ensysce Biosciences To Carry Out 1-for-15 Reverse Stock Split On December 6th, 2024
Ensysce Biosciences Announces Partnership With Specialty Drug Manufacturer